MANUFACTURERS LIFE INSURANCE COMPANY, THE - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$6,590,019
-15.4%
131,223
+6.4%
0.00%0.0%
Q2 2023$7,793,002
+55.7%
123,307
+10.9%
0.00%
+33.3%
Q1 2023$5,003,923
+23.9%
111,223
+19.0%
0.00%0.0%
Q4 2022$4,039,689
-24.4%
93,498
+15.2%
0.00%
-25.0%
Q3 2022$5,344,719
+67.6%
81,142
+31.2%
0.00%
+100.0%
Q2 2022$3,188,274
-22.1%
61,852
-2.3%
0.00%
-33.3%
Q1 2022$4,090,543
+28.0%
63,312
+114.7%
0.00%
+50.0%
Q4 2021$3,196,000
+4.3%
29,490
-1.1%
0.00%
-33.3%
Q3 2021$3,064,000
+6.4%
29,805
-8.9%
0.00%
+50.0%
Q2 2021$2,879,000
-4.3%
32,728
+5.8%
0.00%
-33.3%
Q1 2021$3,009,000
-18.4%
30,945
-5.9%
0.00%0.0%
Q4 2020$3,689,000
+25.3%
32,890
+3.5%
0.00%0.0%
Q3 2020$2,945,000
+19.8%
31,772
-1.1%
0.00%
+50.0%
Q2 2020$2,459,000
+26.5%
32,122
-3.4%
0.00%0.0%
Q1 2020$1,944,000
-17.0%
33,248
+13.8%
0.00%0.0%
Q4 2019$2,341,000
+6.2%
29,225
-3.0%
0.00%0.0%
Q3 2019$2,205,000
-27.7%
30,133
-6.8%
0.00%
-50.0%
Q2 2019$3,049,000
+41.5%
32,316
+20.1%
0.00%
+100.0%
Q1 2019$2,155,000
+57.3%
26,910
+6.0%
0.00%0.0%
Q4 2018$1,370,000
-34.3%
25,398
-5.0%
0.00%0.0%
Q3 2018$2,086,000
+7.9%
26,724
-12.3%
0.00%0.0%
Q2 2018$1,934,000
-32.7%
30,459
-2.8%
0.00%
-33.3%
Q1 2018$2,873,000
+18.4%
31,325
-2.7%
0.00%0.0%
Q4 2017$2,427,000
+18.3%
32,186
+9.3%
0.00%
+50.0%
Q3 2017$2,052,000
+35.6%
29,438
-1.4%
0.00%0.0%
Q2 2017$1,513,000
+126.8%
29,862
+79.2%
0.00%
+100.0%
Q1 2017$667,000
+68.4%
16,668
+17.8%
0.00%0.0%
Q4 2016$396,000
-6.2%
14,144
-0.4%
0.00%0.0%
Q3 2016$422,000
+44.5%
14,201
-1.5%
0.00%
Q2 2016$292,000
+135.5%
14,411
+99.8%
0.00%
Q1 2016$124,000
-32.2%
7,212
+3.7%
0.00%
Q4 2015$183,000
+26.2%
6,953
+2.5%
0.00%
Q3 2015$145,000
-17.6%
6,784
+2.2%
0.00%
Q2 2015$176,0006,6400.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders